FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2065461165> ?p ?o ?g. }

• W2065461165 endingPage "320" @default.
• W2065461165 startingPage "312" @default.
• W2065461165 abstract "A series of aromatic/heterocyclic sulfonamides incorporating valproyl moieties were prepared to design antiepileptic compounds possessing in their structure two moieties known to induce such a pharmacological activity: valproic acid, one of the most widely used antiepileptic drugs, and the sulfonamide residue included in acetazolamide and topiramate, two carbonic anhydrase inhibitors with antiepileptic properties. Some of these derivatives showed very high inhibitory potency against three carbonic anhydrase (CA) isozymes, such as CA I, CA II, and CA IV, involved in important physiological processes. Topiramate, a recently developed antiepileptic drug possessing a sulfamate moiety, also shares this property, although earlier literature data reported this compound to be a weak−moderate CA I, II, and IV inhibitor. The valproyl derivative of acetazolamide (5-valproylamido-1,3,4-thiadiazole-2-sulfonamide, 6M) was one of the best hCA I and hCA II inhibitor in the series and exhibited very strong anticonvulsant properties in an MES test in mice. In consequence, other 1,3,4-thiadiazolesulfonamide derivatives possessing potent CA inhibitory properties and substituted with different alkyl/arylcarboxamido/sulfonamido/ureido moieties in the 5 position have been investigated for their anticonvulsant effects in the same animal model. It was observed that some lipophilic derivatives, such as 5-benzoylamido-, 5-toluenesulfonylamido-, 5-adamantylcarboxamido-, and 5-pivaloylamido-1,3,4-thiadiazole-2-sulfonamide, show promising in vivo anticonvulsant properties and that these compounds may be considered as interesting leads for developing anticonvulsant or selective cerebrovasodilator drugs." @default.
• W2065461165 created "2016-06-24" @default.
• W2065461165 creator A5012797490 @default.
• W2065461165 creator A5020685154 @default.
• W2065461165 creator A5035652477 @default.
• W2065461165 creator A5064498787 @default.
• W2065461165 creator A5081430054 @default.
• W2065461165 date "2001-12-19" @default.
• W2065461165 modified "2023-10-02" @default.
• W2065461165 title "Carbonic Anhydrase Inhibitors: Anticonvulsant Sulfonamides Incorporating Valproyl and Other Lipophilic Moieties" @default.
• W2065461165 cites W1549224984 @default.
• W2065461165 cites W1585542991 @default.
• W2065461165 cites W1636000036 @default.
• W2065461165 cites W1785397469 @default.
• W2065461165 cites W1945125297 @default.
• W2065461165 cites W1964363319 @default.
• W2065461165 cites W1970354875 @default.
• W2065461165 cites W1971968210 @default.
• W2065461165 cites W1977285400 @default.
• W2065461165 cites W1988539482 @default.
• W2065461165 cites W1991361170 @default.
• W2065461165 cites W1998427250 @default.
• W2065461165 cites W2007580188 @default.
• W2065461165 cites W2010630369 @default.
• W2065461165 cites W2013734749 @default.
• W2065461165 cites W2024535919 @default.
• W2065461165 cites W2025183758 @default.
• W2065461165 cites W2030710147 @default.
• W2065461165 cites W2033002582 @default.
• W2065461165 cites W2040481962 @default.
• W2065461165 cites W2044044962 @default.
• W2065461165 cites W2045049503 @default.
• W2065461165 cites W2054963396 @default.
• W2065461165 cites W2063261072 @default.
• W2065461165 cites W2063753799 @default.
• W2065461165 cites W2076436731 @default.
• W2065461165 cites W2077629555 @default.
• W2065461165 cites W2086518334 @default.
• W2065461165 cites W2090582904 @default.
• W2065461165 cites W2095035365 @default.
• W2065461165 cites W2107966379 @default.
• W2065461165 cites W2111008899 @default.
• W2065461165 cites W2117923452 @default.
• W2065461165 cites W2118262335 @default.
• W2065461165 cites W2156290068 @default.
• W2065461165 cites W2165630646 @default.
• W2065461165 cites W2170080849 @default.
• W2065461165 cites W2170446546 @default.
• W2065461165 cites W2323471917 @default.
• W2065461165 cites W2327690082 @default.
• W2065461165 cites W2404144897 @default.
• W2065461165 cites W2950513644 @default.
• W2065461165 cites W4233746703 @default.
• W2065461165 cites W4243253613 @default.
• W2065461165 cites W4249203888 @default.
• W2065461165 cites W4379363646 @default.
• W2065461165 doi "https://doi.org/10.1021/jm0109199" @default.
• W2065461165 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11784136" @default.
• W2065461165 hasPublicationYear "2001" @default.
• W2065461165 type Work @default.
• W2065461165 sameAs 2065461165 @default.
• W2065461165 citedByCount "136" @default.
• W2065461165 countsByYear W20654611652012 @default.
• W2065461165 countsByYear W20654611652013 @default.
• W2065461165 countsByYear W20654611652014 @default.
• W2065461165 countsByYear W20654611652015 @default.
• W2065461165 countsByYear W20654611652016 @default.
• W2065461165 countsByYear W20654611652017 @default.
• W2065461165 countsByYear W20654611652018 @default.
• W2065461165 countsByYear W20654611652019 @default.
• W2065461165 countsByYear W20654611652020 @default.
• W2065461165 countsByYear W20654611652021 @default.
• W2065461165 countsByYear W20654611652022 @default.
• W2065461165 countsByYear W20654611652023 @default.
• W2065461165 crossrefType "journal-article" @default.
• W2065461165 hasAuthorship W2065461165A5012797490 @default.
• W2065461165 hasAuthorship W2065461165A5020685154 @default.
• W2065461165 hasAuthorship W2065461165A5035652477 @default.
• W2065461165 hasAuthorship W2065461165A5064498787 @default.
• W2065461165 hasAuthorship W2065461165A5081430054 @default.
• W2065461165 hasConcept C114373084 @default.
• W2065461165 hasConcept C169760540 @default.
• W2065461165 hasConcept C181199279 @default.
• W2065461165 hasConcept C185592680 @default.
• W2065461165 hasConcept C202751555 @default.
• W2065461165 hasConcept C2775858608 @default.
• W2065461165 hasConcept C2775914622 @default.
• W2065461165 hasConcept C2776568683 @default.
• W2065461165 hasConcept C2776980637 @default.
• W2065461165 hasConcept C2777172819 @default.
• W2065461165 hasConcept C2777405951 @default.
• W2065461165 hasConcept C2778186239 @default.
• W2065461165 hasConcept C2781039511 @default.
• W2065461165 hasConcept C42219234 @default.
• W2065461165 hasConcept C55493867 @default.
• W2065461165 hasConcept C71240020 @default.
• W2065461165 hasConcept C71924100 @default.
• W2065461165 hasConcept C86803240 @default.

• next